A person’s immune system produces antibodies to combat the virus after vaccination.
The assay is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of neutralizing antibodies after vaccination to SARS-CoV-2 in human whole blood, serum or plasma.
Facts:
The limit of detection has been evaluated at 0.1 ng/mL.
Sensitivity: 98,8%
Specificity: 99.6%
Accuracy: 99,2%
